JMP Securities analyst Silvan Tuerkcan has maintained their neutral stance on GBIO stock, giving a Hold rating yesterday.Stay Ahead of the ...

The gene therapy for an undisclosed central nervous system disease is based on JCR's delivery technology and Modalis' epigenome editing platform.

Canine hookworms are becoming increasingly resistant to drugs across Australia, according to research published in the ...

This important manuscript presents a thorough analysis of trans-specific polymorphism (TSP) in Major Histocompatibility Complex gene families across primates. The analysis makes the most of currently ...

Although metabolic dysfunction-associated steatotic liver disease (MASLD) has been proposed to replace the diagnosis of non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria since ...

Thirty-one members of the University of Chicago faculty have received distinguished service professorships or named ...

JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease: Hyogo, Japan Tuesday, January 7, 20 ...

The latest recommendations are presented for the treatment and prevention of HIV, including new antiretroviral therapies ...

Jan. 6, 2025 — A new study has identified 11 genes that may hold the key to understanding the brain's response to these pervasive chemicals commonly found in ...

USC clinicians discuss the risk for bleeding incidents, such as intracranial hemorrhage, in patients with ITP as well as rescue treatment and subsequent management. COVID-19: Trial, Error, and ...